Literature DB >> 17082919

Phosphorylation-dependent metal binding by alpha-synuclein peptide fragments.

Lucy L Liu1, Katherine J Franz.   

Abstract

Alpha-synuclein (alpha-syn) is the major protein component of the insoluble fibrils that make up Lewy bodies, the hallmark lesions of Parkinson's disease. Its C-terminal region contains motifs of charged amino acids that potentially bind metal ions, as well as several identified phosphorylation sites. We have investigated the metal-binding properties of synthetic model peptides and phosphopeptides that correspond to residues 119-132 of the C-terminal, polyacidic stretch of human alpha-syn, with the sequence Ac-Asp-Pro-Asp-Asn-Glu-Ala-Tyr-Glu-Met-Pro-Ser-Glu-Glu-Gly (alpha-syn119-132). The peptide pY125 replaces tyrosine with phosphotyrosine, whereas pS129 replaces serine with phosphoserine. By using Tb(3+) as a luminescent probe of metal binding, we find a marked selectivity of pY125 for Tb(3+) compared with pS129 and alpha-syn119-132, a result confirmed by isothermal titration calorimetry. Truncated or alanine-substituted peptides show that the phosphoester group on tyrosine provides a metal-binding anchor that is supplemented by carboxylic acid groups at positions 119, 121, and 126 to establish a multidentate ligand, while two glutamic acid residues at positions 130 and 131 contribute to binding additional Tb(3+) ions. The interaction of other metal ions was investigated by electrospray ionization mass spectrometry, which confirmed that pY125 is selective for trivalent metal ions over divalent metal ions, and revealed that Fe(3+) and Al(3+) induce peptide dimerization through metal ion cross-links. Circular dichroism showed that Fe(3+) can induce a partially folded structure for pY125, whereas no change was observed for pS129 or the unphosphorylated analog. The results of this study show that the type and location of a phosphorylated amino acid influence a peptide's metal-binding specificity and affinity as well as its overall conformation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17082919     DOI: 10.1007/s00775-006-0181-y

Source DB:  PubMed          Journal:  J Biol Inorg Chem        ISSN: 0949-8257            Impact factor:   3.358


  70 in total

1.  Brain iron deposition in Parkinson's disease imaged using the PRIME magnetic resonance sequence.

Authors:  J M Graham; M N Paley; R A Grünewald; N Hoggard; P D Griffiths
Journal:  Brain       Date:  2000-12       Impact factor: 13.501

2.  De novo design of a molecular switch: phosphorylation-dependent association of designed peptides.

Authors:  Rachel S Signarvic; William F DeGrado
Journal:  J Mol Biol       Date:  2003-11-14       Impact factor: 5.469

3.  Phosphorylation of an alpha-synuclein peptide fragment enhances metal binding.

Authors:  Lucy L Liu; Katherine J Franz
Journal:  J Am Chem Soc       Date:  2005-07-13       Impact factor: 15.419

4.  Impact of the acidic C-terminal region comprising amino acids 109-140 on alpha-synuclein aggregation in vitro.

Authors:  Wolfgang Hoyer; Dmitry Cherny; Vinod Subramaniam; Thomas M Jovin
Journal:  Biochemistry       Date:  2004-12-28       Impact factor: 3.162

5.  Metal-catalyzed oxidation of alpha-synuclein: helping to define the relationship between oligomers, protofibrils, and filaments.

Authors:  Nelson B Cole; Diane D Murphy; Jacob Lebowitz; Luca Di Noto; Rodney L Levine; Robert L Nussbaum
Journal:  J Biol Chem       Date:  2004-12-21       Impact factor: 5.157

6.  Aggregation/fibrillogenesis of recombinant human prion protein and Gerstmann-Sträussler-Scheinker disease peptides in the presence of metal ions.

Authors:  Fernanda Ricchelli; Raffaella Buggio; Denise Drago; Mario Salmona; Gianluigi Forloni; Alessandro Negro; Giuseppe Tognon; Paolo Zatta
Journal:  Biochemistry       Date:  2006-05-30       Impact factor: 3.162

7.  Modulating amyloid self-assembly and fibril morphology with Zn(II).

Authors:  Jijun Dong; Jacob E Shokes; Robert A Scott; David G Lynn
Journal:  J Am Chem Soc       Date:  2006-03-22       Impact factor: 15.419

8.  Iron and aluminum increase in the substantia nigra of patients with Parkinson's disease: an X-ray microanalysis.

Authors:  E C Hirsch; J P Brandel; P Galle; F Javoy-Agid; Y Agid
Journal:  J Neurochem       Date:  1991-02       Impact factor: 5.372

Review 9.  Neurodegenerative diseases and oxidative stress.

Authors:  Kevin J Barnham; Colin L Masters; Ashley I Bush
Journal:  Nat Rev Drug Discov       Date:  2004-03       Impact factor: 84.694

Review 10.  Neurodegenerative diseases: an overview of environmental risk factors.

Authors:  Rebecca C Brown; Alan H Lockwood; Babasaheb R Sonawane
Journal:  Environ Health Perspect       Date:  2005-09       Impact factor: 9.031

View more
  13 in total

Review 1.  Interaction between alpha-synuclein and metal ions, still looking for a role in the pathogenesis of Parkinson's disease.

Authors:  Marco Bisaglia; Isabella Tessari; Stefano Mammi; Luigi Bubacco
Journal:  Neuromolecular Med       Date:  2009       Impact factor: 3.843

Review 2.  Application of metal coordination chemistry to explore and manipulate cell biology.

Authors:  Kathryn L Haas; Katherine J Franz
Journal:  Chem Rev       Date:  2009-10       Impact factor: 60.622

3.  Time-resolved luminescence detection of spleen tyrosine kinase activity through terbium sensitization.

Authors:  Andrew M Lipchik; Laurie L Parker
Journal:  Anal Chem       Date:  2013-02-15       Impact factor: 6.986

4.  A time-resolved luminescence biosensor assay for anaplastic lymphoma kinase (ALK) activity.

Authors:  Wei Cui; Laurie L Parker
Journal:  Chem Commun (Camb)       Date:  2014-11-18       Impact factor: 6.222

5.  KINATEST-ID: a pipeline to develop phosphorylation-dependent terbium sensitizing kinase assays.

Authors:  Andrew M Lipchik; Minervo Perez; Scott Bolton; Vasin Dumrongprechachan; Steven B Ouellette; Wei Cui; Laurie L Parker
Journal:  J Am Chem Soc       Date:  2015-02-17       Impact factor: 15.419

Review 6.  α-Synuclein Misfolding Versus Aggregation Relevance to Parkinson's Disease: Critical Assessment and Modeling.

Authors:  Ruben Berrocal; Velmarini Vasquez; Sambasiva Rao Krs; Bharathi S Gadad; K S Rao
Journal:  Mol Neurobiol       Date:  2014-08-20       Impact factor: 5.590

7.  Phosphorylation of cyclin-dependent kinase 2 peptides enhances metal binding.

Authors:  Graham S Baldwin
Journal:  Biochem Biophys Res Commun       Date:  2008-12-25       Impact factor: 3.575

8.  Phosphorylation of α-Synuclein at Y125 and S129 alters its metal binding properties: implications for understanding the role of α-Synuclein in the pathogenesis of Parkinson's Disease and related disorders.

Authors:  Yu Lu; Michel Prudent; Bruno Fauvet; Hilal A Lashuel; Hubert H Girault
Journal:  ACS Chem Neurosci       Date:  2011-09-14       Impact factor: 4.418

9.  Controlling peptide folding with repulsive interactions between phosphorylated amino acids and tryptophan.

Authors:  Alexander J Riemen; Marcey L Waters
Journal:  J Am Chem Soc       Date:  2009-10-07       Impact factor: 15.419

Review 10.  Implication of Alpha-Synuclein Phosphorylation at S129 in Synucleinopathies: What Have We Learned in the Last Decade?

Authors:  Abid Oueslati
Journal:  J Parkinsons Dis       Date:  2016       Impact factor: 5.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.